Is vomiting normal after oral antimalarials in pediatric patients?
Is it normal for a paediatric patient to take oral anti malarial medication and vomit?
Summary
Vomiting after oral antimalarial medication is a common and recognized side effect in pediatric patients, particularly with drugs like mefloquine and artemether-lumefantrine, affecting tolerability and often requiring re-dosing or split regimens. It is not "normal" in the sense of being harmless or rare but is a well-documented clinical challenge that impacts treatment efficacy and adherence.[1][2][3][4]
Clinical Evidence
Multiple studies confirm that vomiting is frequent following oral antimalarials in children. For mefloquine, a review of over 6,000 pediatric cases noted vomiting as a key tolerability issue, especially at higher doses (e.g., 25 mg/kg), leading to recommendations for split dosing (15 mg/kg initially, followed 12 hours later).[3] In prospective studies of 3,673 patients (including children ≥6 months), early vomiting (within 1 hour) occurred in 7%, with higher risk in children ≤6 years (relative risk 3.9).[4] Artemether-lumefantrine also shows increased early vomiting risk in infants and young children (6-24 months) compared to alternatives like dihydroartemisinin-piperaquine.[2] Taste bitterness exacerbates this, prompting taste-masked formulations.[1][5]
Risk Factors
- Age and weight: Higher incidence in young children (e.g., <6 years, 5-12 kg) due to faster clearance and taste sensitivity.[3][4]
- Dose and regimen: High single doses increase vomiting; split dosing mitigates this.[3][4]
- Drug-specific: Mefloquine and artemether-lumefantrine are most implicated; incidence up to 76% in some comparisons.[6][1][2]
- Malaria severity: Acute infection may worsen GI symptoms.[7]
Management and Clinical Decision-Making
Re-dosing is standard if vomiting occurs within 1 hour, per surveys on pediatric practices.[8][9][10] WHO-aligned guidelines recommend:
- Split mefloquine doses for treatment.[3]
- Monitor for dehydration; consider antiemetics if recurrent.
- Switch to rectal/parenteral if persistent vomiting prevents oral intake.[11][12]
Recent pharmacokinetic data support weight-band dosing to optimize exposure while minimizing GI effects.[13][14] In resource-limited settings, community health workers advise re-administration of vomited doses.[10]
Patient Safety
Vomiting risks treatment failure via reduced bioavailability, especially if not re-dosed, and contributes to resistance.[1][2][4] No severe long-term effects reported beyond dehydration, but high doses link to higher vomiting rates.[4] Monitor for electrolyte imbalance; contraindicated in severe vomiting without re-dosing protocol. Taste-masking (e.g., resin complexes) improves compliance.[1]
Variability Considerations
Efficacy varies by population: higher clearance in older children (5-12 years) vs. infants.[3] Genetic factors (e.g., taste perception) and co-morbidities (e.g., gastroenteritis) influence response.[7] African trials show consistent patterns, but data gaps exist for non-falciparum species.[15][16]
Sources
- https://www.mdpi.com/1424-8247/17/7/870
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2946759/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3215676/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2486817/
- https://wjbphs.com/sites/default/files/WJBPHS-2023-0029.pdf
- https://www.turkarchotolaryngol.net/articles/comparative-analysis-of-preoperative-sedation-modalities-oral-midazolam-and-ketamine-versus-chloral-hydrate-and-meperidine-in-pediatric-tonsillectomy-a-randomized-clinical-trial/doi/tao.2024.2023-12-14
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7866346/
- https://jppt.kglmeridian.com/view/journals/jppt/27/5/article-p457.xml
- http://www.cjhp-online.ca/index.php/cjhp/article/view/1142
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3612059/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2721050/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8097454/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11561580/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10140824/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3818443/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5733786/
- https://linkinghub.elsevier.com/retrieve/pii/S2768276525000185
- https://saudijournals.com/media/articles/SJNHC_81_8-19.pdf
- https://sjemed.com/?mno=193804
- https://www.frontiersin.org/articles/10.3389/fped.2024.1440322/full
- https://journals.lww.com/00001665-201509000-00035
- http://journals.sbmu.ac.ir/dentistry/article/view/24547
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4316276/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC89749/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3123603/
- https://foliamedica.bg/article/58995/download/pdf/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1291940/
- https://academicjournals.org/journal/AJPP/article-full-text-pdf/24A321728696.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10029306/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7022795/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3507524/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6051527/
- https://www.mdpi.com/1999-4923/15/4/1076/pdf?version=1679907478
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3122405/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2846956/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4348099/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11076639/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4468927/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3837842/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5781272/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11671106/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11115045/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC127390/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3591904/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC438896/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9543763/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5881584
- https://pmc.ncbi.nlm.nih.gov/articles/PMC270697/
- https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.041277-0
- http://www.mjhid.org/index.php/mjhid/article/view/2012.064
AI-generated answer based on the cited sources. Check the sources before applying it.